Experts have found a new COVID-19 strain despite the coronavirus vaccine bringing a glimmer of hope to everyone. Could the existing COVID-19 vaccine work on it?
Around this time last year, the small company of Novavax was on the verge of closing down. Today, they are one of the world's leading developers of the coronavirus vaccine.
Russia's Sputnik V was met by mixed reactions from the world as some are happy and others are questioning its safety. In particular, Dr. Anthony Fauci is questioning the safety of Russia's coronavirus vaccine amid concerns that nations are cutting corners to win the vaccine race.
The Gamaleya vaccine is the first the receive regulatory approval in the world after two months of testing. Scientists around the world are skeptic, including the Association of Clinical Trials Organizations, of its efficacy and safety.
The United States continues to struggle with handling the pandemic due to a 'diversity of response' to regulations. However, Dr. Fauci and other experts remain hopeful yet realistic about vaccine developments and drug treatments.
Scientists are using 3D printers to create miniature human organs that will be used to test potential COVID-19 drugs. Bioprinting will help not only COVID-19 patients but patients with cancer and other diseases as well.
Dr. Anthony Fauci says a virus will be available by next year the earliest and urges politicians to shut down states again. Meanwhile, the CDC announces lingering symptoms in young adults while urging schools to reopen by fall.
The deal stated that the 100 million doses of coronavirus vaccine is free to Americans, although health care providers could charge for administration. The deal would also allow the federal government to acquire an additional 500 million doses of the Pfizer vaccine.
The Oxford-AstraZeneca and CanSino vaccine candidates have both shown promising results in their early trials. As they now both enter phase three clinical trials, experts are hopeful that the vaccine candidates would continue to produce good results.